3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
申请人:——
公开号:US20030199478A1
公开(公告)日:2003-10-23
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
3-(Arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
申请人:——
公开号:US20030225152A1
公开(公告)日:2003-12-04
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
申请人:Andrews W. Steven
公开号:US20060025413A1
公开(公告)日:2006-02-02
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
申请人:Andrews W. Steven
公开号:US20060063940A1
公开(公告)日:2006-03-23
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.